AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

AORT · NYSE · Medical - Devices

Artivion (AORT)

Builds devices, sealants, valves, and preservation services for cardiac and vascular surgery.

$24.62

After hours+0.48 (+1.99%)

At close$24.14(+2.16%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	88	94	97	98	96	97	99	113	113	116	116	126
Cost of revenue	32	33	34	35	35	36	35	40	39	46	45	45
Gross profit	56	61	63	63	61	62	64	73	74	70	72	81
	58	58	38	57	57	59	61	65	62	62	64	89
Research & development	6	8	7	7	7	7	7	7	8	9	9	9
	51	50	31	49	50	51	55	58	55	53	55	80
General & administrative	0	0	0	0	0	0	0	0	0	0	0	80
Other expenses	0	0	0	0	0	0	0	0	−1	0	0	0
Operating income	−1	3	25	7	4	3	2	8	13	7	7	−8
	−8	−4	−13	−9	−6	−19	−4	−5	−5	−1	−7	−3
Interest income	0	0	0	0	0	0	0	0	0	0	0	0
Interest expense	7	6	8	8	8	10	8	7	6	6	5	7
Other non-operating income	2	−2	5	1	−3	10	−3	−2	−1	−5	2	−4
Income before tax	−9	−1	13	−2	−1	−17	−2	3	7	7	0	−12
Income tax expense	0	3	5	0	1	0	−2	2	1	4	−1	2
Net income from continuing operations	−10	−4	8	−2	−2	−16	−1	1	7	2	1	−14
Net income	−10	−4	8	−2	−2	−16	−1	1	7	2	1	−14
EPS, basic	−$0.24	−$0.10	$0.18	−$0.05	−$0.05	−$0.39	−$0.01	$0.03	$0.14	$0.05	$0.03	−$0.28
EPS, diluted	−$0.24	−$0.10	$0.18	−$0.05	−$0.05	−$0.39	−$0.01	$0.03	$0.13	$0.05	$0.03	−$0.28
Weighted average shares, basic	41	41	41	42	42	42	42	44	47	48	48	49
Weighted average shares, diluted	41	41	48	42	42	42	42	45	49	50	50	49
EBITDA	3	11	27	12	13	−1	11	16	19	18	12	9
Depreciation & amortization	6	6	6	6	6	6	5	6	6	6	6	13
EBIT	−3	6	21	6	7	−7	5	11	13	12	6	−4